Cardiogenic shock etiology and exit strategy impact survival in patients with Impella 5.5.

McKenzie SickeShan ModiYeahwa HongMichael J BashlineWyatt KlassEd HornBarinder S HansraRaj RamananJeffrey FowlerNikita SumzinRyan M RivosecchiRahul ChaudharyLuke A ZieglerNicholas R HessNishant AgrawalDavid J KaczorowskiGavin W Hickey

Published in: The International journal of artificial organs (2023)

ADHF-CS patients with Impella 5.5 support have a significantly higher rate of survival than patients with AMI-CS. ADHF patients were successfully bridged to heart transplant more often than AMI patients, contributing to increased survival.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
acute myocardial infarction
peritoneal dialysis
heart failure
prognostic factors
coronary artery disease
patient reported outcomes
acute coronary syndrome
left ventricular